Search

Overall, major burn wounds may require special care and long-term hospitalization as they not only bring complications from the wound itself, but may also compromise the immune system, or even other organs. Previous studies have indicated that topical insulin cream shortened wound closure time in second-degree burns in rats. Transplanted adipose-derived stem cells (AD-MSCs) have been developed as an alternative to treat burns and to accelerate the healing process. The aim of the present study is to investigate the effect of topical insulin gel, associated with AD-MSCs intradermal administration to heal second-degree burn wounds in rat models who were subjected to second-degree dorsal burns. The models were divided into four groups (n = 10 per group): placebo gel (C), topical insulin gel (TI), topical insulin gel and adipose-derived mesenchymal stem cells (TIMSCs) and placebo gel and adipose-derived mesenchymal stem cells (CMSCs). Wounds were assessed on a daily basis and histological evaluations were made on 5 animals from each group on the seventh and fourteenth day. There was a significant macroscopic decrease in burn wound areas in the Control (P = 0.0083), TIMSCs and CMSCs (P = 0.042) groups between the seventh and fourteenth days. The TI treatment did not show any significant change (P > 0.05) throughout this same period. The histological analysis showed significant granulation tissue formation in CMSCs and TIMSCs (P = 0.02235) treatments during the experimental period. According to the results, intradermal administration of allogenic AD-MSCs in experimental second-degree burns for short periods of time in the rat model has contributed to reducing the inflammatory phase duration, improving wound re-epithelialization, tissue granulation and wound contraction, as well as increasing collagen deposition.

The aim of the study was to evaluate the effectiveness of midazolam in combination with lidocaine to induce caudal analgesia and cervical dilation to facilitate endometrial biopsy procedures. Eighteen mares undergoing endometrial biopsy were randomly allocated to three treatments groups that received epidural anesthesia (n = 6): 0.9% saline solution (SS) (6 mL, control group); midazolam maleate (MID) (0.05 mg/kg); and midazolam maleate (0.05 mg/kg) plus 2% lidocaine (MIDLID) (0.1 mg/kg). Systemic parameters, behavior, and motor blockade were measured at baseline and at 10, 30, and 60 minutes after treatments. A subjective score system was used to assess pain and cervical dilation during the reproductive procedures at the same time points. Satisfactory analgesia was recorded for both epidural midazolam treatment groups 8 ± 4 minutes postadministration of the drug; analgesia remained satisfactory until the end of the trial period (60 minutes, P > .05). All animals in the control group showed evident pain ( P = .001) due to the analgesic tests and reproductive procedures. Cervical dilation ( P = .0001) occurred 20 minutes after epidural injections for both treatment groups with midazolam, but this effect did not occur in the control treatment group. Systemic effects were not observed ( P > .05) in baseline values or among treatment groups following caudal epidural administration of midazolam or midazolam/lidocaine treatments. Epidural analgesia using midazolam alone or the combination of midazolam and lidocaine may be a good alternative for painful reproductive and gynecologic procedures in mares.

The objective of the study was to compare the effects of caudal epidural bupivacaine and dexmedetomidine (DEX) combination, with bupivacaine or DEX plain for perineal analgesia in mares. Six healthy saddle mares weighing 330–370 kg and aged 10–15 years were used in this study. Each mare was assigned to receive three treatments: 0.04 mg/kg 0.25% bupivacaine (BP), 2 μg/kg DEX (DX), or 0.02 mg/kg bupivacaine and 1 μg/kg DEX (BPDX). The order of treatments was randomized. All drugs were injected into the caudal epidural space (Co1-Co2) through a 16-G Tuohy epidural needle. After the epidural injections, heart rate, respiratory rate, arterial blood pressures (systolic, diastolic, and mean), and rectal temperature were measured at 5, 10, 15, 30, 60, 90, and 120 minutes, and after this time, every 60 minutes until the end of the experiments. A subjective score system was used to assess analgesia, behavioral and motor blockade at the same time points. The BPDX treatment produced analgesic action with twice the duration (200 minutes) of the BP treatment (97 minutes), but with an analgesic duration shorter than the DX treatment (240 minutes) in the regions of the tail, perineum, and upper hind limbs in mares. All treatments showed mild motor blockade. No behavioral changes were observed in any of the animals. There was hemodynamic stability without significant changes in respiratory rate for all treatments. Epidural analgesia using DEX alone or the combination of DEX and bupivacaine may be an option for painful obstetric and gynecological procedures in mares.

This study aimed to evaluate the impact of subarachnoid anesthesia with ketamine during transcervical artificial insemination (TCAI) on the welfare of ewes and on subsequent pregnancy rates. Ninety Suffolk adult ewes were randomized into three treatment groups: control group (CG), which underwent the TCAI procedure as established by cervical traction (CG; n = 30) and two groups that received subarachnoid anesthesia with ketamine at a dose of either 0.75 mg/kg (KE0.75; n = 30) or 1.5 mg/kg (KE1.5; n = 30) 5 min before the cervical traction procedure. Intrauterine insemination was performed using frozen semen from three males previously analyzed and approved for fertility. The use of subarachnoid anesthesia decreased ewes’ vocalizations (P = 0.0001) and abdominal contraction (P = 0.0150) during cervical manipulations. The CG had more groans and vocalizations at the moment of cervix clamping and applicator passage through the cervix (P = 0.001). The cervix traction was facilitated by anesthesia. For the control group, most of the cervical traction was done just up to the middle of the vagina (P = 0.0021). Pregnancy rates increased significantly with anesthesia (P = 0.04) as shown by the rates of 40.0%, 56.7%, and 66.7% for CG, KE1.5, and KE0.75, respectively. The CG showed behaviors associated with absolute immobility, which is suggestive of distress. In brief, the use of ketamine in subarachnoid anesthesia for transcervical artificial insemination in ewes facilitated cervical traction, increased the pregnancy rate, and improved animal welfare.

The use of mesenchymal stem cells (MSCs) in experimental, clinical, and therapeutic trials has grown in recent years. However, the issue remains of whether these procedures are completely safe for transplant patients. Therefore, this study was designed and carried out with the aim of evaluating two different comet assay protocols for genomic damage pattern analysis in MSCs derived from adipose tissue. The analyzed and interpreted results suggest that genetic testing is needed to support clonal expansion safety in cell therapy procedures with MSCs. Furthermore, they also suggest that if the comet assay technique would be used as a genomic integrity screening assay, the protocol performed at pH = 12 (that yielded a frequency of damaged cells: tail intensity = 9.50 ± 0.60, tail moment = 0.0122 ± 0.0007; results are reported as means ± standard deviation) would be indicated as genomic damage, and that subsequent single-strand breaks occur at pH13 (frequency of damaged cells: tail intensity = 30.71 ± 4.23, tail moment = 0.0447 ± 0.0073). Our study demonstrates that, in the era of regenerative medicine, it is necessary to standardize and establish a battery of tests in order to identify genomic damage prior to MSC transplantation.

Six healthy, female, mixed-breed 18–24-month-old sheep weighing 30–48 kg were submitted to lumbosacral epidural bupivacaine in combination with either methadone or fentanyl. Epidural catheters were placed in six sheep that were given three treatments: (Bup) bupivacaine (0.5 mg/kg) alone; (BupMet) bupivacaine (0.25 mg/kg) plus methadone (0.3 mg/kg); and (BupFent) bupivacaine (0.25 mg/kg) plus fentanyl (0.002 mg/kg). Haemodynamic variables, respiratory rate, rectal temperature, analgesia by applying a standard painful stimulus, motor block and sedative scores were compared among the three treatments. These parameters were determined before epidural administration and at 5, 10, 20, 30, 60, 90, 120 minutes after treatment administration, and then every 60 minutes thereafter until the end of analgesic effect. Parametrical data were analysed by proc glimmix (SAS) for repeated measures on time and means tested by ls-means. Non-parametrical data were analysed by Fisher's exact test. Duration of analgesia was longer with BupMet (240 minutes) compared with BupFent (180 minutes; P=0.0127), but BupMet was similar to Bup (240 minutes). Both treatments with opioids produced moderate motor blockade. BupMet and BupFent produced mild sedation. Only treatment with bupivacaine alone induced cardiovascular and respiratory rate changes that stayed within acceptable limits.

The current study aims to evaluate the macroscopic and histological effects of autologous mesenchymal stem cells (MSC) and platelet-rich plasma on knee articular cartilage regeneration in an experimental model of osteoarthritis. Twenty-four rabbits were randomly divided into four groups: control group, platelet-rich plasma group, autologous MSC undifferentiated group, and autologous MSC differentiated into chondrocyte group. Collagenase solution was used to induce osteoarthritis, and treatments were applied to each group at 6 weeks following osteoarthritis induction. After 60 days of therapy, the animals were euthanized and the articular surfaces were subjected to macroscopic and histological evaluations. The adipogenic, chondrogenic, and osteogenic differentiation potentials of MSCs were evaluated. Macroscopic and histological examinations revealed improved tissue repair in the MSC-treated groups. However, no difference was found between MSC-differentiated and undifferentiated chondrocytes. We found that MSCs derived from adipose tissue and platelet-rich plasma were associated with beneficial effects in articular cartilage regeneration during experimental osteoarthritis.

horses. Methods: Epidural catheters were placed in 6 saddle horses that then were given 3 treatments: 2% lidocaine (0.2 mg/kg bwt) alone, 2% lidocaine (0.2 mg/kg bwt) plus tramadol (0.5 mg/kg bwt), and 2% lidocaine (0.2 mg/kg bwt) plus neostigmine (1.0 mg/kg bwt). The order of treatments was randomised. Haemodynamic variables, respiratory rate, rectal temperature, analgesia, motor block and behaviour scores were compared among the 3 treatments. These parameters were determined before drug administration (baseline), at 5, 10, 15, 30, 45, 60, 75 and 90 min, and every 30 min thereafter until loss of analgesia. Results: Duration of analgesia was longer with lidocaine plus tramadol (210 12 min) compared with lidocaine plus neostigmine (150 35 min) or lidocaine alone (70 12 min; P

Objective—To evaluate perineal analgesic effects of 3 doses of neostigmine coadministered epidurally with lidocaine to geldings. Animals—6 healthy geldings. Procedures—A few days before each treatment, a catheter was inserted between the first and second coccygeal vertebrae via the caudal approach in each gelding; the catheter tip was threaded approximately 10 cm cranial into the midsacral region. Each horse received 4 epidural treatments: 2% lidocaine (0.2 mg/kg) alone and 3 doses of neostigmine (0.5, 1, or 2 μg/kg) coadministered with that same dose of lidocaine. Horses were restrained in stocks in a standing position. Heart rate, blood pressure, respiratory rate, rectal temperature, intestinal motility, analgesia, behavior, and ataxia were determined before treatment (time 0; baseline); at 5, 10, 15, 30, 45, 60, 75, and 90 minutes; and every 30 minutes thereafter until the cessation of analgesia. Results—All doses of neostigmine coadministered with lidocaine improved and extended the duration of analgesia in the perineal region of the geldings. Total duration of analgesia was not a dose-dependent effect (120, 150, and 150 minutes for 0.5, 1, and 2 μg/kg, respectively). All treatments induced mild or moderate ataxia. Cardiovascular changes were within acceptable limits. Conclusions and Clinical Relevance—Administration of neostigmine (1 μg/kg) combined with lidocaine (0.2 mg/kg) in the caudal epidural space induced analgesia for 2.5 hours with a low prevalence of adverse effects in standing conscious geldings. Epidural doses of neostigmine greater than these should be avoided because they may cause undesirable effects in geldings.

A enxertia cutânea se caracteriza pelo transplante de um segmento de epiderme e derme sem comunicação com o local de origem, o que a diferencia dos retalhos e flapes cutâneos. É uma excelente opção para recobrimento de lesões extensas em que existe a impossibilidade de recobrir o defeito com retalhos ou por aproximação. As diferentes técnicas cirúrgicas existentes oferecem ao cirurgião possibilidades para se obter sucesso em lesões extensas em que existem tensão e ausência de tecido suficiente para o fechamento. Para que este sucesso seja alcançado cuidados com a coleta do enxerto, preparo correto do leito receptor, cuidados pós operatórios devem ser minimamente seguidos para que a completa revascularização do enxerto seja alcançada.

To determine the analgesic and systemic effects of thoracic epidural administration of bupivacaine (BP) and morphine (MP) in conscious sheep.Randomized, crossover, experimental study.Six healthy castrated sheep weighing between 40 and 50 kg.Each sheep received, via the lumbosacral approach, BP (0.5 mg kg(-1)), MP (0.1 mg kg(-1)), and BP plus MP (BPMP; 0.25 mg kg(-1) + 0.05 mg kg(-1)) in a randomized order. Heart rate, blood pressure, respiratory rate, blood gas analysis, skin temperature, rectal temperature, analgesia, sedation, and motor blockade were determined before treatment and at predetermined intervals until analgesia had disappeared.The main areas of complete analgesia for the BP and BPMP treatments were the thorax and forelimb bilaterally. The median duration of analgesia was shorter with MP treatment (45 minutes; score 2) than with BP treatment (70 minutes) and BPMP treatment (140 minutes; p0.05). The BP and BPMP treatments caused motor block, and MP and BPMP treatments showed mild sedation. Significant decreases in systolic and diastolic arterial blood pressures were observed only with the BP treatment (p0.05). Epidural MP combined with the BP local anesthetic depressed ventilation but within acceptable limits in these clinically healthy sheep.Thoracic epidural administration of BPMP to sheep resulted in longer duration of analgesia of the thorax and forelimbs bilaterally in conscious sheep than the administration of MP or BP alone. The incidence of complications was low, but side-effects such as depressed ventilation and muscle paralysis occurred and require appropriate management.This technique should be considered as another method for the relief of postoperative pain after thoracic surgery in sheep.

The aim of this study was to compare the effects of caudal epidural bupivacaine alone (BP), bupivacaine plus morphine (BPMP), and bupivacaine plus ketamine (BPKE) for perineal analgesia in horses. Each of the six saddle horses received a caudal epidural catheter and underwent 3 treatments: BP, 0.25% (0.04 mg/kg) bupivacaine hydrochloride without epinephrine; BPMP, 0.02 mg/kg of bupivacaine combined with 0.1 mg/kg of morphine-preservative free; and BPKE, 0.02 mg/kg of bupivacaine combined with 0.5 mg/kg of ketamine. The order of treatments was randomized. The cardiovascular system, respiratory rate, quality of analgesia, sedation, and motor blockade were assessed before drug administration (baseline), at 5, 10, 15, and 30 minutes, and every 30 minutes thereafter until loss of analgesia. The median time to onset of analgesia was 5 minutes after BP treatment, faster than after BPKE or BPMP treatments, which were 10 minutes and 15 minutes, respectively (P < .05). The BPMP treatment produced analgesia (315 minutes) for a longer duration than BP treatment (210 minutes) or BPKE treatment (240 minutes), in the regions of the tail, perineum, and upper hind limb in horses. All treatments presented mild sedation or motor blockade. There were minimal effects on the cardiovascular system and respiratory rate. BPMP may be preferable to a high dose of BP or BPKE. Caudal epidural BPMP can be an appropriate choice for regional perineal analgesia in horses.

Objectives: The aim of this study was to evaluate the effects of hyaluronidase added to levobupivacaine in lumbosacral epidural blockade in dogs. Methods: Six adult mixed breed dogs (two males and four females) weighing 7 to 14 kg (10·5 ±1·5 kg) and aged two to five years were used. Each dog received both treatments in random order: levobupivacaine alone (LBA; n=6) or levobupivacaine plus hyaluronidase (LBH; n=6) administered in the lumbosacral epidural space. Systemic effects, spread and duration of anaesthesia and motor block were determined before treatment and at predetermined intervals. Results: The duration of local anaesthesia was 90 ±10 minutes (P=0·001) for LBH treatment and 150 ±15 minutes for LBA treatment. In the LBH treatment, anaesthesia reached the T12 to T13 dermatome and in the LBA treatment it reached the T11 to T12 dermatome in all animals in 5 and 15 minutes, respectively. Complete motor blockade was 75 ±12 minutes (P=0·01) and 120 ±15 minutes for LBH and LBA treatments, respectively. Clinical Significance: Hyaluronidase added to levobupivacaine significantly shortens the duration of epidural anaesthesia with the same dermatome spread into the epidural space in dogs.

Objective: The objective of this study was to assess whether the volume or concentration of local anesthetic influences its spread and quality of lumbosacral epidural blockade when the total drug dose is fixed.Methods: A total of 30 healthy bitches, undergoing elective ovariohysterectomy received a lumbosacral epidural block with a fixed dose of 0.5 mg/kg b.w. bupivacaine after general anesthesia induction with propofol. Treatment 1 group (low volume, high concentration [LVHC], n=15) received 0.2 mL/kg b.w. of 0.25% bupivacaine, whereas treatment 2 group (high volume, low concentration [HVLC], n=15) received 0.3 ml/kg b.w. of 0.167% bupivacaine. Both solutions contained radio-opaque dye. Heart rate, blood pressure, respiratory rate, rectal temperature, cranial spread, first analgesic rescue, and motor blockade were determined at predetermined intervals.Results: At 5 min, the dorsal cranial spread levels of bupivacaine confirmed by radiographic examination were T8 (T1–T10) for HVLC treatment and T8 (T6–T10) for LVHC treatment (p=0.957). However, there was a significant difference (p=0.029) in the ventral spread levels between HVLC treatment (T2; C7-T6) and LVHC treatment (T6; T5–T11). The first analgesic rescue was needed after 249±58 min in the LVHC treatment group and after 179±32 min in the HVLC treatment group (p=0.0005).Conclusion: It was concluded, if the total dose is fixed, then administration of an HVLC bupivacaine local anesthetic solution in the lumbosacral epidural space seems to produce effective post-operative analgesia for ovariohysterectomy surgery in bitches.

Objective To determine the analgesic and systemic effects of epidural administration of ketamine, lidocaine or a combination of ketamine/lidocaine in standing cattle. Study design Prospective, randomized, experimental trial. Animals Six healthy male cattle weighing between 335 and 373 kg. Methods The animals received 0.5 mg kg−1 of ketamine (K), 0.2 mg kg−1 of 2% lidocaine (L) or 0.25 mg kg−1 ketamine plus 0.1 mg kg−1 lidocaine (KL). All the drugs were injected into the dorsolumbar epidural space via a caudal approach through a non‐styletted multiple‐port catheter. Each animal received each treatment at random. Evaluations of analgesia, sedation, ataxia, heart rate, arterial pressure, respiratory rate, skin temperature and rectal temperature were obtained at 0 (basal), 5, 10, 15, 30, 45, 60, 75, 90 minutes after epidural injection, and then at 30‐minute intervals until loss of analgesia occurred. Skin temperature was taken at these intervals up to 60 minutes. All the animals received a standard noxious stimulus; a 4‐point scale was used to score the response. A second scale was used to score ataxia and a third for sedation. Results The duration of analgesia in the upper and lower flanks in cattle was 140 ± 15, 50 ± 14 and 80 ± 22 minutes (mean ± SD) after dorsolumbar epidural KL, K or L, respectively. The cardiovascular changes were within acceptable limits in these clinically healthy cattle. Conclusions Dorsolumbar epidural administration of KL to cattle resulted in longer duration of analgesia of the upper and lower flanks in standing conscious cattle, than the administration of K or L alone. Clinical relevance Further research is necessary to determine whether this combination using this technique provides sufficient analgesia for flank surgery in standing cattle.

Objective To determine the anaesthetic and systemic effects of dorsolumbar epidural anaesthesia using non-stylet multiport catheters via the caudal approach to administer hypertonic 5% lignocaine (HL) or hypertonic 0.5% bupivacaine (HB) to the flank in standing cattle. Materials and methods Six healthy adult cattle weighing 310–455 kg received 0.2 mg/kg HL or 0.025 mg/kg of HB; control animals received 0.9% saline solution. All drugs were injected into the dorsolumbar epidural space via a caudal approach through a non-stylet multiport catheter. Each animal received each treatment at random. Evaluations of anaesthesia, ataxia, heart rate, arterial pressures, respiratory rate and rectal temperature were obtained at 0 (basal), 5, 10, 15, 30, 45, 60, 75, and 90 min after epidural injection and then at 30-min intervals until loss of anaesthesia. All animals received a standard noxious stimulus and a 4-point scale was used to score the response. A second scale was used to score ataxia. Results The duration of anaesthesia in the upper and lower flanks in cattle was 68 ± 12 and 110 ± 15 min (mean ± SD) after dorsolumbar epidural HL or HB, respectively. Both hypertonic local anaesthetics produced a mild ataxia. The systemic changes were within acceptable limits in these clinically healthy cattle. Conclusion In standing cattle the dorsolumbar epidural injection of hypertonic lignocaine provided faster onset of anaesthesia and fewer cardiovascular effects, but had a shorter duration of anaesthesia than hypertonic bupivacaine.

In order to determine the analgesic and cardiovascular effects of the combination of epidural ketamine and lidocaine, 6 sedated cats were studied. Six healthy, young cats were used in a prospective randomised study. Each cat underwent 3 treatments, at least 1 week apart, via epidural injection: (1) ketamine (2.5 mg/kg), (2) lidocaine (4.0 mg/kg), and (3) ketamine (2.5 mg/kg) plus lidocaine (4.0 mg/kg). Epidural injections were administered through the lumbosacral space. Analgesia, motor block, sedation, heart rate, arterial blood pressure, respiratory rate and arterial oxygen saturation were measured. Rectal temperature was compared before and after sedation as well as after epidural administration of the drugs. Epidural administration of the ketamine/lidocaine combination induced prolonged analgesia extending from the coccygeal to the T13-L1 dermatomes, leading to severe ataxia. Cardiovascular effects were significant in all treatments: heart rate decreased, but there was a minimal reduction in arterial pressure. It was concluded that adding a dose of ketamine to epidural lidocaine in cats is feasible and effective.

The cervical anatomy limits the use of trans-cervical artificial insemination (AI) and embryo transfer in ewes. Thus, the objective of the study was to evaluate the sub-arachnoid administration of ketamine as a tool to be used in cervical dilation of the ewe. The following experimental treatments were used: in Experiment 1, animals (n = 6) were treated with the sub-arachnoid administration of ketamine (KS, 1.5 mg kg−1); and in Experiment 2, one tablet of misoprostol was diluted in 1.5 ml saline and deposited near the cervical os, 5 h before the trial + oxytocin administered i.v. 5 min before the reproductive procedures (MO, 200 + 20 U.I., respectively). In Experiment 3, animals received sub-arachnoid ketamine + misoprostol/oxytocin (KSMO). The systemic effects, analgesia, sedation, and motor neuron block were evaluated before each experiment and at pre-determined time intervals thereafter. A subjective score system was used to assess pain and discomfort during the reproductive manipulations in the different experiments. The mean duration of analgesia in the sternal decubitus position without sedation was 30 ± 4 and 25 ± 7 min for the KS and KSMO treatments, respectively. All treatments provided sufficient cervical dilation for the passage of the insemination rod into the uterus. The ketamine sub-arachnoid treatment alone produced a complete cervical dilation, allowing easy passage of the rod. Further studies are needed to establish whether this anesthetic technique may interfere with fertility, pregnancy or lambing rate in ewes during AI or embryo transfer.

The objective of this study was to determine the sedation, analgesia, and clinical reactions induced by an intravenous combination of romifidine and butorphanol in horses. The study was conducted on six saddle horses weighing 382 to 513 kg (mean ± SD; 449 ± 54 kg) and aged 6 to 14 years. The horses each underwent three treatments: intravenous romifidine 0.1 mg/kg body weight (RM; mean dose, 4.5 mL); intravenous butorphanol 0.05 mg/kg body weight (BT; mean dose, 2.4 mL); and intravenous romifidine 0.1 mg/kg body weight plus butorphanol 0.05 mg/kg body weight (RMBT; mean dose, 7.0 mL). The order of treatments was randomized. Heart rate, arterial pressure, respiratory rate, rectal temperature, sedation, and analgesia were measured at two times before treatments, 15 minutes apart (times –15 and 0) and at 5, 10, 15, 30, 45, 60, 75, 90, 120, 150, and 180 minutes after drug administration. The onset of sedation was approximately 5 minutes after intravenous injection of RM and RMBT, whereas BT did not present this effect. The duration of complete sedation was approximately 60 minutes for RMBT and approximately 35 minutes for RM. The RMBT treatment provided 30 minutes and the RM treatment 20 minutes of complete analgesia. Heart rate decreased significantly ( P P P > .05) in any treatment. Intravenous administration of a romifidine−butorphanol combination to horses resulted in longer duration of sedation and analgesia than administration of romifidine or butorphanol alone. These effects probably resulted from a synergistic effect of the two drugs.

Objectives The aim of the study was to evaluate the effectiveness of epidural lidocaine in combination with either methadone or morphine for postoperative analgesia in cats undergoing ovariohysterectomy. Methods Under general anesthesia, 24 cats that underwent ovariohysterectomy were randomly allocated into three treatment groups of eight each. Treatment 1 included 2% lidocaine (4.0 mg/kg); treatment 2 included lidocaine and methadone (4.0 mg/kg and 0.3 mg/kg, respectively); and treatment 3 included lidocaine and morphine (4.0 mg/kg and 0.1 mg/kg, respectively). All drugs were injected in a total volume of 0.25 ml/kg via the lumbosacral route in all cats. During the anesthetic and surgical periods, the physiologic variables (respiratory and heart rate, arterial blood pressure and rectal temperature) were measured at intervals of time zero, 10 mins, 20 mins, 30 mins, 60 mins and 120 mins. After cats had recovered from anesthesia, a multidimensional composite pain scale was used to assess postoperative analgesia 2, 4, 8, 12, 18 and 24 h after epidural. Results The time to first rescue analgesic was significantly ( P Conclusions and relevance The two combinations administered via epidural allowed ovariohysterectomy with sufficient analgesia in cats, and both induced prolonged postoperative analgesia.

Six adult goats were subjected to three treatments with a minimum of a 1-week interval between the treatments. All animals received 3.0 mg kg −1 ketamine (KE), 2.5 mg kg −1 lidocaine (LI) or 1.5 mg kg −1 ketamine and 1.25 mg kg −1 lidocaine (KELI). All the drugs were injected into the lumbosacral subarachnoid space. Analgesia, ataxia, sedation, cardiovascular and respiratory effects, and rectal temperature were recorded at different intervals before (baseline) and after drug administration. The duration of antinociception after subarachnoid ketamine/lidocaine administration was 127 ± 30 min (mean ± S.D.), i.e., more than twice that obtained with ketamine (49 ± 13 min) or lidocaine (66 ± 31 min) alone. After subarachnoid administration of ketamine, lidocaine, and ketamine/lidocaine, all goats had ataxia and subsequent sternal recumbency. None of the treatments significantly altered the cardiovascular and respiratory functions. Treatment with ketamine alone caused mild sedation. Subarachnoid administration of ketamine/lidocaine to goats resulted in longer duration of analgesia of the tail, perineum, hind limbs, flank, and caudodorsal rib areas, than the administration of ketamine or lidocaine alone. A longer duration of analgesia probably occurred as a synergistic effect of the two drugs. Thus, was concluded that this combination could be used subarachnoidally in goats requiring prolonged surgery.

The objective of the study was to determine the analgesic and systemic effects of subarachnoid administration of xylazine hydrochloride (XY), lidocaine hydrochloride (LI) and their combination (XYLI) in goats. Six healthy goats were used in a prospective randomised study. Three treatments were administered to each goat, with 1-week intervals between each treatment. Treatments consisted of 0.1 mg/kg xylazine, 2.5 mg/kg lidocaine and a combination of xylazine 0.05 (mg/kg) and lidocaine (1.25 mg/kg). Analgesia, ataxic, sedative, cardiovascular and respiratory effects, and rectal temperature were evaluated before (baseline) and at 5, 10, 15, and 30 min after subarachnoid injection, and then at 30-min intervals until loss of analgesia occurred. Lidocaine induced analgesia in 3.1 + 1min (mean + SD), which lasted for 66 + 31 min. Heart and respiratory rates and blood pressure remained unchanged after lidocaine-induced analgesia. Xylazine induced analgesia in 9.5 + 2.6 min and xylazine-lidocaine in 3.2 + 1.2 min. Xylazine-lidocaine-induced analgesia lasted longer (178.3 + 37 min) than that induced by xylazine (88.3 + 15 min). The XYLI treatment induced prolonged motor blocking (115 min), more than the XY (80 min) and LI (90 min) treatments. Both xylazine and xylazine-lidocaine caused significant decreases in the heart and respiratory rates, but not in blood pressure. The combination of xylazine (0.05 mg/kg) and lidocaine (1.25 mg/kg) can be administered subarachnoidally (between last lumbar vertebra and 1st sacral vertebra) to produce prolonged (2.5 h) analgesia of the tail, perineum, hind limbs, flanks and caudodorsal rib areas in goats. Despite the prolonged analgesia, using this combination is desirable for relieving postoperative pain, but it may be a disadvantage due to a motor block when dealing with goats.

Bupivacaine is available as a racemic mixture of its enantiomers, d-bupivacaine and l-bupivacaine (LB). The aim of this randomized, double-blind study was to investigate the clinical efficacy and safety of S(-)-bupivacaine compared with standard racemic bupivacaine (RB) in horses under caudal epidural analgesia. Two treatments were administered to each horse, with a 2-week interval between subsequent treatments. Treatment 1 consisted of 0.5% LB at a dose of 0.06 mg/kg of body weight, and treatment 2 consisted of 0.5% RB at a dose of 0.06 mg/kg of body weight. Epidural injections were given in all animals between the first and second coccygeal vertebra. Heart rate (HR), arterial pressures, respiratory rate (RR), rectal temperature (RT), analgesia, and motor blocking were determined before drug administration (basal) and 5, 10, 15 and 30 min after drug administration, and at 30 min intervals thereafter. There were no significant differences between the two treatments in the quality of sensory and motor block. The duration of analgesia was 320 +/- 30 min (mean +/- SD) for RB and 360 +/- 42 min for LB. HRs and RRs, arterial pressures and RT did not change (P < 0.05) significantly from basal values after epidural administration of LB or RB. This study supports that 0.5% LB is an effective alternative to RB in caudal epidural analgesia in conscious, standing horses. The use of LB vs. RB warrants further investigation, particularly for long-lasting surgery in the perineal region.

This study aimed at comparing lidocaine 2% plain with lidocaine 5% with glucose 7.5% for caudal epidural analgesia in horses. Eighteen clinically healthy mixed breed horses were studied. The animals were randomly divided into three treatments: lidocaine plain (LID) treatment received 0.20 mg/kg of body weight (mean dose 3.2 mL); heavy lidocaine (HLID) treatment received 0.5 mg/kg of body weight (mean dose 3.2 mL), and 0.9% saline solution (SS) 5 mL as a control treatment. All drugs were injected by the epidural route in all animals between the first and second coccygeal space. Heart rate, arterial pressure, respiratory rate, rectal temperature, analgesia, and motor-blocking were determined before drug administration (baseline values); at 5, 10, 15, and 30 minutes after drug administration, and then at 30-minute intervals thereafter. The onset of analgesia was 7.5 minutes ± 2.7 minutes after injection of hyperbaric lidocaine, opposed to 11.7 minutes ± 4 minutes after lidocaine plain. The duration of analgesia was 156 minutes ± 17.4 minutes for hyperbaric lidocaine and 115 minutes ± 16 minutes for lidocaine plain. Heart rate and arterial pressure did not change ( P P

Subarachnoid administration of clonidine and xylazine produces antinociception in several species and in humans. The present study compares these two drugs administered by the subarachnoid route to goats. Goats (n=6) were randomly assigned to three treatment groups. All animals of each group received 0.06 mg kg−1 clonidine (CLO), 0.1 mg kg−1 xylazine (XIL) and 0.9% saline solution (SS), with a minimum interval of 1 week between treatments. All injections were made into the subarachnoid space between the last lumbar vertebra and the first sacral vertebra. Analgesia, ataxia, sedation, cardiovascular and respiratory effects, and rectal temperature were evaluated at predefined regular time intervals before drug administration (baseline) and after administration. The onset of analgesia by clonidine and xylazine was observed in 6.8±1.8 and 9.5±2.6 min (mean±S.D.), respectively. Both α2-agonists produced analgesia of dorsocaudal rib areas, flanks, hind limbs, perineum and tail, sedation and ataxia. The duration of antinociception after clonidine administration was 118.8±24 min and after xylazine 88.3±15 min (mean±S.D.). Clonidine and xylazine subarachnoidally administered induced a significant (P

O objetivo deste experimento foi comparar o bloqueio sensitivo e motor produzido pela administracao subaracnoidea debupivacaina 0,5% hiperbarica e a lidocaina 2% em caprinos. Foram usados seis caprinos (machos e femeas) adultos. Cadaanimal recebeu tres tratamentos: grupo Bup - bupivacaina 0,5% hiperbarica - 0,5 mg/kg (n=6); grupo Lid - lidocaina 2% - 2,5mg/kg (n=6); grupo SS - solucao salina como controle (n=6). Todas injecoes foram feitas no espaco subaracnoideo entre aultima vertebra lombar e a primeira sacra!. A analgesia e o bloqueio motor foram avaliados em intervalos determinados eregulares, sendo o tempo basal (minuto O) antes e os outros intervalos apos a administracao dos farmacos. A bupivacainaproduziu anestesia regional tres vezes mais prolongada (136,5±24,2 min.) que a lidocaina (66,5±31 ,3 min.). O bloqueio motorno grupo que recebeu bupivacaina finalizou antes que o bloqueio sensitivo. A extensao do bloqueio sensitivo no grupo 8up foisuperior alcancando ate o dermatomo T8±2. O inicio do bloqueio sensitivo e motor foram similares para ambos farmacos.Concluimos que a bupivacaina utilizada produziu um tempo de bloqueio sensitivo superior quanto ao tempo de duracao eextensao do que a lidocaina, com minimos efeitos motores.

This study investigated the analgesic and systemic effects of intramuscular (IM) versus epidural (EP) administration of tramadol as an adjunct to EP injection of lidocaine in cats. Six healthy, domestic, shorthair female cats underwent general anesthesia. A prospective, randomized, crossover trial was then conducted with each cat receiving the following 3 treatments: EP injection of 2% lidocaine [LEP; 3.0 mg/kg body weight (BW)]; EP injection of a combination of lidocaine and 5% tramadol (LTEP; 3.0 and 2.0 mg/kg BW, respectively); or EP injection of lidocaine and IM injection of tramadol (LEPTIM; 3.0 and 2.0 mg/kg BW, respectively). Systemic effects, spread and duration of analgesia, behavior, and motor blockade were determined before treatment and at predetermined intervals afterwards. The duration of analgesia was 120 ± 31 min for LTEP, 71 ± 17 min for LEPTIM, and 53 ± 6 min for LEP (P0.05; mean ± SD). The cranial spread of analgesia obtained with LTEP was similar to that with LEP or LEPTIM, extending to dermatomic region T13-L1. Complete motor blockade was similar for the 3 treatments. It was concluded that tramadol produces similar side effects in cats after either EP or IM administration. Our findings indicate that EP and IM tramadol (2 mg/kg BW) with EP lidocaine produce satisfactory analgesia in cats. As an adjunct to lidocaine, EP tramadol provides a longer duration of analgesia than IM administration. The adverse effects produced by EP and IM administration of tramadol were not different. Further studies are needed to determine whether EP administration of tramadol could play a role in managing postoperative pain in cats when co-administered with lidocaine after painful surgical procedures.La présente étude visait à déterminer les effets analgésiques et systémiques de l’administration intramusculaire (IM) ou épidurale (EP) de tramadol comme un ajout à l’injection EP de lidocaïne chez des chats. Six chattes domestiques à poils courts ont été soumises à une anesthésie générale. Une étude prospective croisée aléatoire a été menée, chaque chat recevant les trois traitements suivants : injection EP de lidocaïne 2 % [LEP; 3,0 mg/kg poids corporels (PC)]; injection EP d’une combinaison de lidocaïne et de tramadol 5 % (LTEP; 3,0 et 2,0 mg/kg PC, respectivement); ou injection EP de lidocaïne et injection IM de tramadol (LEPTIM; 3,0 et 2,0 mg/kg PC, respectivement). Les effets systémiques, l’étendue et la durée de l’analgésie, le comportement, et le blocage moteur furent déterminés avant le traitement et à des intervalles prédéterminés par la suite. La durée de l’analgésie était de 120 ± 31 min pour LTEP, 71 ± 17 min pour LEPTIM, et 53 ± 6 min pour LEP (

Objective The aim of this study was to evaluate the combination of bupivacaine and methadone administered epidurally in sheep. Methods Six healthy female mixed-breed sheep weighing 35–46 kg and aged 12–18 months were included. Each sheep was assigned to receive three treatments: 0.5 mg/kg 0.25% bupivacaine (BP), 0.3 mg/kg 1% methadone (MT) or 0.25 mg/kg bupivacaine and 0.15 mg/kg methadone (BPMT). All drugs were injected into the lumbosacral space through an epidural catheter. Each animal received each treatment at random. Heart rate, arterial blood pressure (systolic, diastolic and mean), respiratory rate, rectal temperature, analgesia, sedation and motor block were determined before treatment and at predetermined intervals. Results The duration of analgesia was 240, 220, and 180 min for BP, MT and BPMT, respectively (P < 0.05). Motor block for all agents was mild to moderate. None or the treatments significantly altered the heart rate, blood pressure or respiratory rate. Conclusion Our findings suggest that lumbosacral epidural administration of bupivacaine, methadone or a combination of the two drugs can provide perioperative analgesia in sheep as part of their management for surgical procedures in the flank and hindlimbs.

Foram aplicadas, experimentalmente, anestesia epidural caudal com apenas quetamina ou associada a lidocaina paraavaliar sua eficiencia na especie equina. Atualmente, existem evidencias clinicas de interacoes sinergicas das acoes espinhaisentre a combinacao de uma variada gama de farmacos. Estas podem evitar, ou ao menos reduzir, as acoes neurotoxicasque produzem a aplicacao isolada de um dos farmacos, que necessitam para isto doses e/ou concentracoes superiores paraobter a anestesia desejada. Para a realizacao deste experimento utilizamos seis cavalos de pesos e idades variadas, com osseguintes tratamentos: Grupo 1: solucao salina; Grupo 11: quetamina (1 mg/kg); Grupo 111: lidocaina (0,20 mg/kg); e Grupo IV: aassociacao de quetamina (1 mg/kg)/ lidocaina (0,20 mg/kg). Todos os grupos receberam volumes predeterminados e aplicadospor via epidural. Para reduzir a variacao na resposta, o mesmo grupo de animais foi utilizado no experimento com umintervalo de uma semana entre as diferentes aplicacoes. A anestesia foi avaliada mediante a estimulacao dolorosa, utilizandoseuma agulha 23G, e determinando o grau de resposta em uma escala de dor. Os tempos usados foram: basal e 2, 5, 1 O, 15minutos e depois a cada 15 minutos, pos-administracao de quetamina, lidocaina e a associacao de quetamina/lidocaina, oudo grupo controle. Os resultados indicam que o tempo de anestesia e a eficiencia da analgesia produzida pelo grupo quetamina/lidocaina administrada por via epidural foi superior a administracao destas drogas individualmente. Os efeitos cardiorrespiratorios foram minimos em todos os grupos.

OBJETIVO: Determinar os efeitos analgésicos, motores, sedativos e sistêmicos da adição de sulfato de magnésio na analgesia epidural com quetamina em carneiros. MÉTODOS: Foram utilizados seis carneiros machos sadios, pesando 43 ± 5 kg, com idade entre 20 a 36 meses. Cada animal recebeu três tratamentos, com duas semanas entre experimentos via administração epidural: (1) quetamina (KE; 2,5 mg/kg), (2) sulfato de magnésio (MG; 100 mg) e (3) KE + MG (KEMG; 2,5 mg/kg + 100 mg, respectivamente). As administrações epidurais foram administradas no espaço lombosacral. Analgesia, bloqueio motor, sedação, efeitos cardiovasculares, freqüência respiratória, temperatura retal e de pele foram avaliados antes (basal) e depois da administração dos fármacos até o fim da analgesia. RESULTADOS: A duração da analgesia com o tratamento KEMG foi 115 ± 17 min (média ± DP), duas vezes superior ao obtido com o tratamento KE (41 ± 7 min) ou tratamento MG (29 ± 5 min) isolados. Os tratamentos KE e KEMG induziram bloqueio motor severo. As pressões arteriais e freqüência cardíaca não foram estatisticamente significantes nestes animais. CONCLUSÃO: A adição de sulfato de magnésio a analgesia epidural com quetamina é viável, e pode ser usado para prolongar os efeitos analgésicos destes bloqueios em carneiros. ABSTRACT - PURPOSE: To determine the analgesic, motor, sedation and systemic effects of lumbosacral epidural magnesium sulphate added to ketamine in the sheep. METHODS: Six healthy adult male mixed-breed sheep; weighing 43 ± 5 kg and aged 20–36 months. Each sheep underwent three treatments, at least 2 weeks apart, via epidural injection: (1) ketamine (KE; 2.5 mg/kg), (2) magnesium sulphate (MG; 100 mg), and (3) KE + MG (KEMG; 2.5 mg/kg + 100 mg, respectively). Epidural injections were administered through the lumbosacral space. Analgesia, motor block, sedation, cardiovascular effects, respiratory rate, skin temperature, and rectal temperature were evaluated before (baseline) and after drug administration as needed. RESULTS: The duration of analgesia with the lumbosacral epidural KEMG combination was 115 ± 17 min (mean ± SD), that is, more than twice that obtained with KE (41 ± 7 min) or MG (29 ± 5 min) alone. KE and KEMG used in this experiment induced severe ataxia. The heart rate and arterial blood pressures changes were no statistical difference in these clinically health sheep. CONCLUSION: The dose of magnesium sulphate to lumbosacral epidural ketamine in sheep is feasible, and can be used in procedures analgesics in sheep.

Deep second-degree burns (DSDb) involve all epidermis layers, including the basal laminae. In general, DSDb heals with extensive areas of scarring. Platelet-rich plasma (PRP) is a source of growth factors, obtained by centrifugation and addition of thrombin and calcium, resulting in a gel. The objective of this study was to monitor the healing of DSDb by sequential biopsies after PRP treatment and evaluating by a scanning electron microscopy. Also, characterize bacterial profile and PRP antibacterial effect in horses’ burns. Four horses were placed into two groups, G1 and G2, with the groups receiving 1 and 2 treatments of PRP, respectively. Control groups (Gc1 and Gc2) were treated with saline solution. DSDb were made by infliction of hot iron after epidermis dissection. Biopsies were performed 5, 15, 25 and 40 days after PRP treatment, and swab collections were performed 30 days after PRP treatment. At d25, G1 showed a higher amount of fibrils compared with Gc1, and the organization of G2 was similar to that of uninjured tissue. At d40, G1 resembled intact tissue and G2 showed dense tissue. All groups had bacterial contamination but no infection. PRP accelerated repair, induced fibroses and probably provided antibacterial activity in horses with DSDb.

OBJETIVO: Avaliar os efeitos da bupivacaína 0,5 e 0,25 % na anestesia regional endovenosa (IVRA) e no bloqueio do plexo braquial (BPB) respectivamente, na anestesia, bloqueio motor e parâmetros cardiovasculares em cães. MÉTODOS: Foram utilizados 14 cães sadios adultos pesando em média 10 kilos. Animais foram aleatoriamente designados a um de dois tratamentos IVRA (n = 7) ou BPB (n = 7). Todos os animais foram sedados com acepromazina (0,1 mg/kg intramuscular). Para realizar o BPB foi usado um estimulador elétrico nervoso. Anestesia, bloqueio motor, sedação, efeitos cardiovascular e respiratório foram mensurados como efeitos dos respectivos bloqueios. RESULTADOS: O bloqueio BPB demonstrou eficiência superior e maior duração da anestesia (BPB – 456 ± 94 minutos vs IVRA – 138 ± 44 minutos) bem como maior envolvimento motor. Somente a pressão arterial sistólica foi alterada no grupo BPB e a freqüência respiratória em ambos os tratamentos. CONCLUSÃO: Em cães, a bupivacaína 0,25% hiperbárica no grupo BPB produziu uma anestesia do membro anterior três vezes mais longa que a 0,5% no grupo IVRA, com ptose do membro bloqueado e pequena interferência no sistema cardiovascular e com diminuição da freqüência respiratória. ABSTRACT - PURPOSE: To evaluate the effects of bupivacaine 0.5 and 0.25% in intravenous regional anesthesia (IVRA) and brachial plexus block (BPB), respectively, on anesthesia, motor block and cardiovascular parameters in dogs. METHODS: Fourteen healthy adult dogs averaging 10 kilograms (kg) of body weight. Animals were randomly assigned to receive one of the two treatments IVRA (n=7) or BPB (n=7). All the animals were sedated with acepromazine (0.1 mg/kg intramuscular). To execute the BPB was used an electrical nerve stimulation. Anesthesia, motor block, sedation, cardiovascular and respiratory effects were measured as effect of the treatment. RESULTS: BPA showed superior efficiency and duration of anesthesia (BPB - 456 ± 94 minutes vs IVRA – 138 ± 44) as well as motor block. There only physiologic parameter which change were the systolic pressure in BPB and respiratory rate for both treatments. CONCLUSION: In dogs the 0.25 % hyperbaric bupivacaine in BPB produces a front limb anesthesia about three times more than the 0.5 % in IVRA, with ptosis of the limb blocked and little interference in the cardiovascular system but with decrease in respiratory rate.

Objective—To evaluate use of nonstyletted multiple-port catheters for epidural administration of ketamine hydrochloride via the caudal approach to induce analgesia of the paralumbar fossa (flank) in cattle. Animals—6 healthy bulls. Procedures—1 week before experiments began, a multiple-port catheter was inserted by use of a Tuohy needle in all cattle via the caudal approach (between the first and second coccygeal vertebrae); the tip was threaded approximately 48 cm cranial into the dorsolumbar region. Each bull was administered ketamine (0.3, 0.5, or 0.7 mg/kg) at time 0. Heart rate, blood pressures, respiratory rate, rectal temperature, analgesia, sedation, and ataxia were determined before treatment (baseline [time 0]); at 5, 10, 15, 30, 45, 60, 75, and 90 minutes; and every 30 minutes thereafter until end of analgesia. Results—All multiple-port catheters were threaded with negligible resistance into the dorsolumbar region in all bulls. All doses of ketamine were effective for inducing analgesia of the flank region of bulls in a standing position. Total analgesia time was dose dependent (35, 50, and 80 minutes for 0.3, 0.5, and 0.7 mg/kg, respectively). All doses of ketamine induced mild or moderate ataxia. Heart rate changes were within acceptable limits. Conclusions and Clinical Relevance—Segmental dorsolumbar epidural analgesia with ketamine administered via multiple-port catheters by use of the caudal approach in cattle was feasible, and the cattle remained standing with minimal adverse effects. Further studies are necessary to determine whether this technique provides optimal conditions to allow surgery in standing cattle.

PURPOSE: To establish a low-cost method to prepare platelet-rich plasma (PRP) and evaluates the potential of platelet derived factors to enhance wound healing in the surgical wounds in equine. METHODS: To obtain a PRP gel, calcium gluconate and autologous thrombin were added to platelet-rich plasma. For the tests six saddle horses were used and two surgical incisions were made in each animal. Wounds were treated with PRP gel or untreated. Sequential wound biopsies collected at Treatment 1: at days 5 and 30 and Treatment 2: at days 15 and 45 post wounding permitted comparison of differentiation markers and wound repair. RESULTS: The optimal platelets enrichment over 4.0 time's baseline values was obtained using 300 g for 10 min on the first centrifugation and 640 g for 10 min on the second centrifugation. CONCLUSION: Wounds treated with PRP gel exhibit more rapid epithelial differentiation and enhanced organization of dermal collagen compared to controls in equine. OBJETIVO: Estabelecer um método econômico na preparação de plasma rico em plaquetas (PRP) e avaliar se os fatores derivados destas plaquetas aceleram a cicatrização de feridas cirúrgicas em cavalos. MÉTODOS: Gluconato de cálcio e trombina autógena foram adicionados ao PRP para a obtenção do gel de PRP. Foram usados seis cavalos de sela, cada um dos quais sofreu duas incisões cirúrgicas. Uma destas incisões foi tratada com gel de PRP e a outra suturada de maneira tradicional (controle). A biópsia das feridas foi coletada de maneira seqüencial; Tratamento 1. nos dias 5 e 30 e Tratamento 2. nos dias 15 e 45 do período pós-operatório permitindo uma comparação na diferenciação epitelial e no reparo das feridas. RESULTADOS: O enriquecimento das plaquetas obtido através de uma primeira centrifugação usando 300 g por 10 minutos e uma segunda 640 g por 10 minutos acelerou quatro vezes a reparação tecidual em relação ao controle. CONCLUSÃO: As feridas tratadas com gel de PRP apresentaram uma mais rápida diferenciação epitelial e acelerou a organização do colágeno da derme comparado ao grupo controle em cavalos.

Six 20-24-month-old heifers received ketamine (KE), 2% lidocaine (Li), or ketamine and 2% lidocaine (KELI) into the first intercoccygeal (Co(1)-Co(2)) epidural space while standing. Heart rate, arterial blood pressure (systolic, diastolic, and mean), respiratory rate, rectal temperature, analgesia, sedation, and ataxia were determined before treatment and at predetermined intervals. Subjective scoring was used to assess pain and discomfort in reproductive manipulations. The duration of analgesia was 35+/-14 min for Li, 48+/-11 min for KE, and 35+/-7 min for KELI (P>0.05). Motor block determined by KE, Li, or KELI treatments was restricted to tail, external genital organs (vulva and vagina), anus, and rectum, with little interference in the cervix or uterus. It was concluded that epidural ketamine, 2% lidocaine, or their combination produced satisfactory analgesia without discomfort or ataxia and facilitated reproductive manipulations.

Clonidine (CL) is a alpha2-adrenergic agonist that produces analgesia in animals and humans by a non-opiate alpha2-adrenergic action in the spinal cord dorsal horn. The objective of this prospective randomized study was to investigate the clinical effects of CL/lidocaine (LD) combination administered by the subarachnoid route in sheep. Each sheep received each of three treatments, at no shorter than weekly intervals. Treatments consisted of 0.003 mg/kg CL, 1.2 mg/kg LD and a combination of CL (0.003 mg/kg) and LD (1.2 mg/kg) (CLLD). Subarachnoid injections were given in all animals between the last lumbar and first sacral vertebra. Heart rate (HR), arterial pressures, respiratory rate, rectal temperature, analgesia, sedation, and motor blockade were determined before drug administration (basal) and 5, 10, 15 and 30 min after drug administration, and at 30-min intervals until loss of analgesia occurred. The duration of analgesia after subarachnoid CLLD administration was 187 +/- 24 min (mean +/- SD), i.e. more than twice of that obtained with CL (99 +/- 19 min) or LD (55 +/- 4.4 min) alone. In all sheep, CL, administered either alone or with LD, induced moderate sedation. After subarachnoid administration of three treatments, all sheep had ataxia and subsequent sternal recumbency. The CL treatment causes decreases in blood pressure (diastolic arterial pressure and mean arterial pressure) and HR. Data suggest that the CLLD combination could be used subarachnoidally in sheep requiring prolonged surgery.

To determine the efficacy and safety of subarachnoid butorphanol combined with lidocaine, six calves were studied. Each calf underwent two treatments, at least one week apart, via subarachnoid injection: (1) butorphanol (0.03 mg/kg) plus 2% lidocaine (4 mg/kg) and (2) 2% lidocaine (4 mg/kg) alone. Subarachnoid injections were performed at the lumbosacral space. Analgesia, motor block, sedation, heart rate, arterial blood pressure, respiratory rate, arterial oxygen saturation as measured by pulse oximetry, and rectal temperature were compared before and after subarachnoid administration of drugs. Subarachnoid administration of the butorphanol-lidocaine combination induced bilateral prolonged analgesia extending from the coccygeal to the T11-T13 dermatomes in the calves, with minimal sedation and severe ataxia. Cardiovascular effects were significant in both treatments: heart rate was increased, and there was a minimal decrease in arterial pressure. It was concluded that adding a small dose of butorphanol to subarachnoid lidocaine in calves is effective and safe.

Epidural administration of bupivacaine and meperidine produces analgesia in several animal species and in humans. A prospective randomized study was conducted in 18 healthy horses to compare the effect of these 2 drugs administered by the epidural route. Animals were divided into 3 treatment groups of 6 animals each. All drugs were injected by the epidural route in all animals between the 1st and 2nd coccygeal vertebrae. Treatment 1 (BUP) — 0.06 mg/kg of body weight of 0.5% hyperbaric bupivacaine; treatment 2 (MEP) — 0.6 mg/kg of body weight of 5% meperidine; treatment 3 (SS) — 0.9% saline solution (control group). Heart rate, arterial pressure, respiratory rate, rectal temperature, analgesia, sedation, and motor-blocking were determined before drug administration (baseline values); at 5, 10, 15, and 30 minutes after drug administration, and then at 30-minute intervals thereafter. Both hyperbaric bupivacaine and meperidine administered epidurally produced complete bilateral perineal analgesia in all horses. The onset of analgesia was 6, s = 2.6 minutes after injection of bupivacaine, as opposed to 9, s = 2 minutes after meperidine. The duration of analgesia was 240, s = 57 minutes for meperidine and 320, s = 30 minutes for bupivacaine. Heart and respiratory rates, arterial pressure, and rectal temperature did not change (P < 0.05) significantly from basal values after the epidural administration of bupivacaine, meperidine, or saline solution. To conclude, both bupivacaine and meperidine induced long-lasting perineal analgesia, with minimal cardiovascular effects. Analgesia was induced faster and lasted longer with bupivacaine.

Objective—To determine the effects of ketamine hydrochloride, xylazine hydrochloride, and lidocaine hydrochloride after subarachnoid administration in goats. Animals—6 healthy goats. Procedure—In each goat, ketamine (3 mg/kg), xylazine (0.1 mg/kg), lidocaine (2.5 mg/kg), and saline (0.9% NaCl) solution were injected into the subarachnoid space between the last lumbar vertebra and first sacral vertebra (time 0). Analgesic, ataxic, sedative, cardiovascular, and respiratory effects and rectal temperature were evaluated before (baseline) and 2, 5, 10, 15, and 30 minutes after administration and at 30-minute intervals thereafter as needed. Results—Administration of anesthetics induced varying degrees of analgesia. Onset of the analgesic effect was more delayed for xylazine (mean ± SD, 9.5 ± 2.6 minutes) than for ketamine (6.7 ± 2.6 minutes) or lidocaine (3.5 ± 1.2 minutes). Duration of analgesia induced by xylazine (88.3 ± 15 minutes) was twice as long as the duration of analgesia induced by ketamine (48.8 ± 13.5 minutes) but similar to that induced by lidocaine (66.5 ± 31 minutes). Xylazine induced bradycardia, whereas ketamine caused a nonsignificant increase in heart rate. Xylazine induced a reduction in arterial pressure, whereas ketamine or lidocaine did not affect arterial pressure. Conclusion and Clinical Relevance—Subarachnoid administration of xylazine in goats resulted in longer duration of analgesia of the tail, perineum, hind limbs, flanks, and caudodorsal rib areas than administration of ketamine or lidocaine. However, xylazine caused bradycardia and respiratory depression. Additional studies are needed to determine whether the analgesia would be sufficient to allow clinicians to perform surgical procedures. (Am J Vet Res 2003;64:51–56)

CERTAIN surgical procedures via the dorsal region of the flank in cattle may be better conducted with the animal in a standing position. Providing anaesthesia via the caudal approach is thought to have advantages over other methods, as not all techniques guarantee complete anaesthesia, and a smaller